Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Che-Yi Chang,1,2,* Ming-Chen Wang,2,* Takuya Miyagawa,1 Zhi-Yu Chen,1 Feng-Huei Lin,3,4 Ko-Hua Chen,5,6 Guei-Sheung Liu,7 Ching-Li Tseng1 1Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 2Department of Biomedic...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang CY, Wang MC, Miyagawa T, Chen ZY, Lin FH, Chen KH, Liu GS, Tseng CL
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
RGD peptide
epigallocatechin gallate (EGCG)
hyaluronic acid (HA)
vascular endothelial cells
anti-angiogenesis
corneal neovascularization
Medicine (General)
R5-920
Online Access:https://doaj.org/article/d182185c1bd64859ac5390338a941c6b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/d182185c1bd64859ac5390338a941c6b

Similar Items